[1]
N. Privšek, S. Borštnar, and C. Grašič Kuhar, “Efficacy and safety of trastuzumab deruxtecan therapy: analysis of real-world data”, Onkologija, vol. 28, no. 2, pp. 30–39, Dec. 2024.